Patents by Inventor Junpei Sasajima

Junpei Sasajima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Revascularization cells derived from mononuclear cells, and method of inducing differentiation thereof
    Patent number: 8951795
    Abstract: The present invention relates to a method of safely and simply inducing differentiation of mononuclear cells into cells that promote neovascular stabilization and maturation, and lead to recovering from ischemia or tissue repair. The cells according to the present invention are obtained by inducing differentiation of a mononuclear cell by culturing the mononuclear cell in a medium (particularly a serum-free medium) containing one or more selected from vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), thrombopoietin (TPO), granulocyte-colony stimulating factor (G-CSF) and FMS-like tyrosine kinase 3 ligand (FLT3L), and collecting a cell population expressing CD11b.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: February 10, 2015
    Assignee: National University Corporation Asahikawa Medical University
    Inventors: Yusuke Mizukami, Junpei Sasajima, Yoshiaki Sugiyama, Kazuya Sato, Yutaka Kohgo
  • REVASCULARIZATION CELLS DERIVED FROM MONONUCLEAR CELLS, AND METHOD OF INDUCING DIFFERENTIATION THEREOF
    Publication number: 20120100610
    Abstract: The present invention relates to a method of safely and simply inducing differentiation of mononuclear cells into cells that promote neovascular stabilization and maturation, and lead to recovering from ischemia or tissue repair. The cells according to the present invention are obtained by inducing differentiation of a mononuclear cell by culturing the mononuclear cell in a medium (particularly a serum-free medium) containing one or more selected from vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), thrombopoietin (TPO), granulocyte-colony stimulating factor (G-CSF) and FMS-like tyrosine kinase 3 ligand (FLT3L), and collecting a cell population expressing CD11b.
    Type: Application
    Filed: March 29, 2010
    Publication date: April 26, 2012
    Applicant: National University Corporation Asahikawa Medical
    Inventors: Yusuke Mizukami, Junpei Sasajima, Yoshiaki Sugiyama, Kazuya Sato, Yutaka Kohgo